~~<i id='67B1E18028'><strike id='67B1E18028'><tt id='67B1E18028'><pre id='67B1E18028'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：explore 2025-09-30 00:37:12 - browse：1

A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron.

“It has been exciting to be involved,” Gorham wrote.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Congress may force more Covid

hotspot

focus

explore

hotspot

leisure time

focus

MarkLennihan/APPfizeronFridaysaiditwasstoppingdevelopmentofatwice-dailyoralobesitymedicationafteranu

WSS

Hospitals are piloting generative AI tools as regulators play catch

Mayo Clinic plans $5B tech

BIO selects John Crowley as new CEO

Flagship Pioneering startup Sonata Therapeutics lays off 21

BIO selects John Crowley as new CEO

The EPA's new lead rule: How one expert crunched the numbers

explore

explore

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Fetal surgery at risk from Dobbs and new abortion restrictions

Duchenne breakthrough therapy leaves behind pioneering families

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Virginia high school admissions case could be legal follow

The EPA's new lead rule: How one expert crunched the numbers

Sports medicine is finally prioritizing gender equality

How to pay for weight loss drugs and save Medicare

Moonlake's readout produced a cash windfall. Risks remain

Congress may force more Covid

focus

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Hospitals are piloting generative AI tools as regulators play catch

A new drug could help frostbite victims avoid its ravages

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Medicare Advantage enrollment grows 7.1% to 33.4 million people

explore

hotspot

leisure time

focus